

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 7.20501625 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.57757793 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.46772461 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.46772461 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.23914208 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.02843609 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.78815014 |
| 8 | NIK/NF-kappaB signaling (GO:0038061) | 4.61207291 |
| 9 | * positive regulation of osteoclast differentiation (GO:0045672) | 4.59644595 |
| 10 | regulation of heat generation (GO:0031650) | 4.44776674 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 4.40591223 |
| 12 | establishment of protein localization to Golgi (GO:0072600) | 4.40154650 |
| 13 | protein targeting to Golgi (GO:0000042) | 4.33355851 |
| 14 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 4.18620093 |
| 15 | growth hormone receptor signaling pathway (GO:0060396) | 4.13075096 |
| 16 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.09043520 |
| 17 | negative T cell selection (GO:0043383) | 4.07379555 |
| 18 | * regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.06102981 |
| 19 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.03141250 |
| 20 | negative thymic T cell selection (GO:0045060) | 4.01675119 |
| 21 | positive regulation of prostaglandin secretion (GO:0032308) | 3.94202980 |
| 22 | neural tube formation (GO:0001841) | 3.91379947 |
| 23 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.88788280 |
| 24 | regulation of fever generation (GO:0031620) | 3.86943711 |
| 25 | DNA double-strand break processing (GO:0000729) | 3.83201851 |
| 26 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.81173527 |
| 27 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.78750467 |
| 28 | positive regulation of B cell differentiation (GO:0045579) | 3.72300140 |
| 29 | positive regulation of granulocyte differentiation (GO:0030854) | 3.67988492 |
| 30 | positive regulation of heat generation (GO:0031652) | 3.67622459 |
| 31 | actin nucleation (GO:0045010) | 3.59987586 |
| 32 | cellular response to growth hormone stimulus (GO:0071378) | 3.50897721 |
| 33 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.49606824 |
| 34 | protein localization to Golgi apparatus (GO:0034067) | 3.40783501 |
| 35 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.40684257 |
| 36 | protein polyglutamylation (GO:0018095) | 3.38923966 |
| 37 | alpha-beta T cell differentiation (GO:0046632) | 3.36763620 |
| 38 | response to interleukin-15 (GO:0070672) | 3.36055449 |
| 39 | T cell selection (GO:0045058) | 3.35898200 |
| 40 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.33131254 |
| 41 | activated T cell proliferation (GO:0050798) | 3.31973318 |
| 42 | positive thymic T cell selection (GO:0045059) | 3.31102042 |
| 43 | * myeloid dendritic cell differentiation (GO:0043011) | 3.29325935 |
| 44 | regulation of T cell tolerance induction (GO:0002664) | 3.28612686 |
| 45 | natural killer cell differentiation (GO:0001779) | 3.28182163 |
| 46 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.25695005 |
| 47 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.24936754 |
| 48 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.24936754 |
| 49 | thymic T cell selection (GO:0045061) | 3.23734568 |
| 50 | * regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.22880831 |
| 51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.17428446 |
| 52 | regulation of cilium movement (GO:0003352) | 3.16641753 |
| 53 | * myeloid dendritic cell activation (GO:0001773) | 3.14593934 |
| 54 | positive regulation of interferon-alpha production (GO:0032727) | 3.13663456 |
| 55 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.11308126 |
| 56 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.11308126 |
| 57 | regulation of B cell differentiation (GO:0045577) | 3.11068829 |
| 58 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.10382869 |
| 59 | regulation of prostaglandin secretion (GO:0032306) | 3.10007135 |
| 60 | regulation of interferon-alpha production (GO:0032647) | 3.09120750 |
| 61 | response to muramyl dipeptide (GO:0032495) | 3.08915785 |
| 62 | tolerance induction (GO:0002507) | 3.07979704 |
| 63 | protein-cofactor linkage (GO:0018065) | 3.07506541 |
| 64 | * positive regulation of interleukin-2 production (GO:0032743) | 3.03562853 |
| 65 | neutrophil activation involved in immune response (GO:0002283) | 3.01160919 |
| 66 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.00902443 |
| 67 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.97106114 |
| 68 | negative regulation of cell killing (GO:0031342) | 2.97106114 |
| 69 | * positive regulation of myeloid leukocyte differentiation (GO:0002763) | 2.95820775 |
| 70 | neutrophil activation (GO:0042119) | 2.91329000 |
| 71 | positive T cell selection (GO:0043368) | 2.89096300 |
| 72 | negative regulation of DNA recombination (GO:0045910) | 2.88539351 |
| 73 | interferon-gamma production (GO:0032609) | 2.88452416 |
| 74 | regulation of fibroblast apoptotic process (GO:2000269) | 2.87054948 |
| 75 | negative regulation of T cell mediated immunity (GO:0002710) | 2.86403518 |
| 76 | thrombin receptor signaling pathway (GO:0070493) | 2.86011362 |
| 77 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.84738783 |
| 78 | adaptation of signaling pathway (GO:0023058) | 2.84438418 |
| 79 | granulocyte activation (GO:0036230) | 2.83090680 |
| 80 | positive regulation of histone deacetylation (GO:0031065) | 2.82795783 |
| 81 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.82478614 |
| 82 | T-helper cell differentiation (GO:0042093) | 2.82478614 |
| 83 | response to lipoprotein particle (GO:0055094) | 2.82221892 |
| 84 | regulation of natural killer cell differentiation (GO:0032823) | 2.81510050 |
| 85 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.81042695 |
| 86 | positive regulation of humoral immune response (GO:0002922) | 2.80942659 |
| 87 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.80438885 |
| 88 | T cell homeostasis (GO:0043029) | 2.80185713 |
| 89 | lymph node development (GO:0048535) | 2.78357817 |
| 90 | hepatocyte apoptotic process (GO:0097284) | 2.77424355 |
| 91 | somite development (GO:0061053) | 2.76374927 |
| 92 | B cell receptor signaling pathway (GO:0050853) | 2.75810651 |
| 93 | protein targeting to lysosome (GO:0006622) | 2.74778454 |
| 94 | establishment of protein localization to vacuole (GO:0072666) | 2.74778454 |
| 95 | protein targeting to vacuole (GO:0006623) | 2.74778454 |
| 96 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.73219291 |
| 97 | response to type I interferon (GO:0034340) | 2.72862478 |
| 98 | positive regulation of defense response to virus by host (GO:0002230) | 2.72817924 |
| 99 | germ cell migration (GO:0008354) | 2.70902571 |
| 100 | regulation of germinal center formation (GO:0002634) | 2.70734359 |
| 101 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.70153052 |
| 102 | T cell migration (GO:0072678) | 2.69854321 |
| 103 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.69484998 |
| 104 | mature B cell differentiation (GO:0002335) | 2.67271663 |
| 105 | negative regulation of interleukin-10 production (GO:0032693) | 2.66569567 |
| 106 | natural killer cell activation (GO:0030101) | 2.66530143 |
| 107 | T cell costimulation (GO:0031295) | 2.66248185 |
| 108 | peptidyl-threonine dephosphorylation (GO:0035970) | 2.65692043 |
| 109 | negative regulation of adaptive immune response (GO:0002820) | 2.65208186 |
| 110 | type I interferon signaling pathway (GO:0060337) | 2.64703449 |
| 111 | cellular response to type I interferon (GO:0071357) | 2.64703449 |
| 112 | cellular response to interleukin-15 (GO:0071350) | 2.63948820 |
| 113 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.63649773 |
| 114 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.63383364 |
| 115 | DNA deamination (GO:0045006) | 2.63123424 |
| 116 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.62004540 |
| 117 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.61971876 |
| 118 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.61260997 |
| 119 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.61260997 |
| 120 | modulation by symbiont of host immune response (GO:0052553) | 2.61260997 |
| 121 | positive regulation by symbiont of host defense response (GO:0052509) | 2.61260997 |
| 122 | modulation by symbiont of host defense response (GO:0052031) | 2.61260997 |
| 123 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.61260997 |
| 124 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.60865416 |
| 125 | Peyers patch development (GO:0048541) | 2.60865416 |
| 126 | lymphocyte costimulation (GO:0031294) | 2.60278682 |
| 127 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.59191927 |
| 128 | negative regulation of T cell apoptotic process (GO:0070233) | 2.59177710 |
| 129 | regulation of chronic inflammatory response (GO:0002676) | 2.59128883 |
| 130 | leukocyte aggregation (GO:0070486) | 2.59006056 |
| 131 | positive regulation of isotype switching (GO:0045830) | 2.58999184 |
| 132 | response to xenobiotic stimulus (GO:0009410) | 2.58579350 |
| 133 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.58402775 |
| 134 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.57142626 |
| 135 | * dendritic cell differentiation (GO:0097028) | 2.56625333 |
| 136 | regulation of hypersensitivity (GO:0002883) | 2.55822238 |
| 137 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.55696739 |
| 138 | T cell proliferation (GO:0042098) | 2.53876439 |
| 139 | DNA demethylation (GO:0080111) | 2.53604841 |
| 140 | iron-sulfur cluster assembly (GO:0016226) | 2.53243593 |
| 141 | metallo-sulfur cluster assembly (GO:0031163) | 2.53243593 |
| 142 | lymphocyte homeostasis (GO:0002260) | 2.52262201 |
| 143 | regulation of tolerance induction (GO:0002643) | 2.52026418 |
| 144 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.51409730 |
| 145 | regulation of necroptotic process (GO:0060544) | 2.50681001 |
| 146 | protein K11-linked deubiquitination (GO:0035871) | 2.50561246 |
| 147 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.48844775 |
| 148 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.48635930 |
| 149 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.48583695 |
| 150 | cytokine biosynthetic process (GO:0042089) | 2.47064840 |
| 151 | phospholipid homeostasis (GO:0055091) | 2.46546447 |
| 152 | JAK-STAT cascade (GO:0007259) | 2.46388583 |
| 153 | * positive regulation of cytokine biosynthetic process (GO:0042108) | 2.46323445 |
| 154 | regulation of feeding behavior (GO:0060259) | 2.46229109 |
| 155 | histone H3-K4 trimethylation (GO:0080182) | 2.46211717 |
| 156 | alpha-beta T cell activation (GO:0046631) | 2.46138876 |
| 157 | necroptotic process (GO:0070266) | 2.45934546 |
| 158 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.44151450 |
| 159 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.44151450 |
| 160 | T cell differentiation involved in immune response (GO:0002292) | 2.44151450 |
| 161 | protein deneddylation (GO:0000338) | 2.44102522 |
| 162 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.44102115 |
| 163 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.44063560 |
| 164 | negative regulation of B cell proliferation (GO:0030889) | 2.43278042 |
| 165 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.42377600 |
| 166 | positive regulation of icosanoid secretion (GO:0032305) | 2.42245694 |
| 167 | defense response to protozoan (GO:0042832) | 2.41338819 |
| 168 | * positive regulation of interleukin-12 production (GO:0032735) | 2.41093753 |
| 169 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.40915661 |
| 170 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.40059246 |
| 171 | positive regulation of bone remodeling (GO:0046852) | 2.39993501 |
| 172 | positive regulation of bone resorption (GO:0045780) | 2.39993501 |
| 173 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.39723173 |
| 174 | positive regulation of antigen processing and presentation (GO:0002579) | 2.39426859 |
| 175 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.39364852 |
| 176 | intracellular lipid transport (GO:0032365) | 2.39355757 |
| 177 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.38798451 |
| 178 | cullin deneddylation (GO:0010388) | 2.36391444 |
| 179 | positive regulation of fatty acid transport (GO:2000193) | 2.34308091 |
| 180 | RNA destabilization (GO:0050779) | 2.32169765 |
| 181 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.32117599 |
| 182 | B cell homeostasis (GO:0001782) | 2.31270698 |
| 183 | regulation of memory T cell differentiation (GO:0043380) | 2.29900228 |
| 184 | cytidine catabolic process (GO:0006216) | 2.29230598 |
| 185 | cytidine deamination (GO:0009972) | 2.29230598 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.39890461 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.83570046 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.49348218 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.23131627 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.18712162 |
| 6 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.68532299 |
| 7 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.40100751 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.17781752 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.12491848 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 3.09499053 |
| 11 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 3.04807544 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.92741969 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.88191798 |
| 14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.85780653 |
| 15 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.84579089 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.75375487 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.72449848 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.68952330 |
| 19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.62169781 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.60161857 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.55482370 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.53455350 |
| 23 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.49164761 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.43862676 |
| 25 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.43673984 |
| 26 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.43446010 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.37699452 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 2.37149743 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 2.32377614 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.32084184 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.31535196 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.30106502 |
| 33 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.29346358 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.22759670 |
| 35 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.21784593 |
| 36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.20612251 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.20139082 |
| 38 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.14828079 |
| 39 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.10971627 |
| 40 | MYB_26560356_Chip-Seq_TH1_Human | 2.09099755 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.06575203 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.03136715 |
| 43 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.03096835 |
| 44 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.99483856 |
| 45 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.98136434 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.96940925 |
| 47 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.96483430 |
| 48 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.89229119 |
| 49 | UTX_26944678_Chip-Seq_JUKART_Human | 1.87898401 |
| 50 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.86449813 |
| 51 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.84209392 |
| 52 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.83447013 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.79577462 |
| 54 | VDR_22108803_ChIP-Seq_LS180_Human | 1.78163305 |
| 55 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.78004701 |
| 56 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.76413932 |
| 57 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.71888600 |
| 58 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.70837004 |
| 59 | EWS_26573619_Chip-Seq_HEK293_Human | 1.69331456 |
| 60 | P300_19829295_ChIP-Seq_ESCs_Human | 1.67216781 |
| 61 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.65867457 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.65050222 |
| 63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.60450735 |
| 64 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.58293953 |
| 65 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.56659326 |
| 66 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.56353387 |
| 67 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.55539847 |
| 68 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.53893918 |
| 69 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.53585519 |
| 70 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.52461714 |
| 71 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.51385710 |
| 72 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.50786530 |
| 73 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.50204260 |
| 74 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.49340919 |
| 75 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.48185519 |
| 76 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47178620 |
| 77 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.46934273 |
| 78 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.46934273 |
| 79 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.46427508 |
| 80 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.46398404 |
| 81 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.46210792 |
| 82 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.45644157 |
| 83 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.45009072 |
| 84 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44933481 |
| 85 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.44785573 |
| 86 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44760840 |
| 87 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.43413558 |
| 88 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.42719200 |
| 89 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.42441364 |
| 90 | SPI1_23127762_ChIP-Seq_K562_Human | 1.41465706 |
| 91 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.40978586 |
| 92 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.40010528 |
| 93 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.38316322 |
| 94 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.38059600 |
| 95 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.37864050 |
| 96 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.37695838 |
| 97 | FUS_26573619_Chip-Seq_HEK293_Human | 1.36544906 |
| 98 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.34232508 |
| 99 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34031301 |
| 100 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.30773366 |
| 101 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30695415 |
| 102 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.30586447 |
| 103 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.30299317 |
| 104 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.29888957 |
| 105 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.28965628 |
| 106 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27900534 |
| 107 | MAF_26560356_Chip-Seq_TH2_Human | 1.27353191 |
| 108 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.27191685 |
| 109 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.27056573 |
| 110 | STAT3_23295773_ChIP-Seq_U87_Human | 1.25744118 |
| 111 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.25673858 |
| 112 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25431265 |
| 113 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.24959155 |
| 114 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.24057658 |
| 115 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.23603372 |
| 116 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23003855 |
| 117 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.21782650 |
| 118 | TP53_16413492_ChIP-PET_HCT116_Human | 1.19700413 |
| 119 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19029820 |
| 120 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.17609453 |
| 121 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.16186660 |
| 122 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.15425165 |
| 123 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14806230 |
| 124 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14337243 |
| 125 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.13769268 |
| 126 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12838254 |
| 127 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.12830839 |
| 128 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.12792078 |
| 129 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12656096 |
| 130 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12546379 |
| 131 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.12363242 |
| 132 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.11916982 |
| 133 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09897429 |
| 134 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.09783769 |
| 135 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.08823122 |
| 136 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.08669225 |
| 137 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.08551154 |
| 138 | * CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.08410573 |
| 139 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.06653015 |
| 140 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.06286660 |
| 141 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05965060 |
| 142 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.05769810 |
| 143 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.03510213 |
| 144 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02524302 |
| 145 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01251794 |
| 146 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.01119836 |
| 147 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.99886951 |
| 148 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.99886951 |
| 149 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.99721941 |
| 150 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.99593953 |
| 151 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98932528 |
| 152 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98853322 |
| 153 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97233694 |
| 154 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96181543 |
| 155 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94509025 |
| 156 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93920735 |
| 157 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93222894 |
| 158 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.90770276 |
| 159 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90287442 |
| 160 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.89510666 |
| 161 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.89510666 |
| 162 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89260046 |
| 163 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.89114621 |
| 164 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.88818426 |
| 165 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87870955 |
| 166 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87236673 |
| 167 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86594058 |
| 168 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.85719573 |
| 169 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.85570614 |
| 170 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84244402 |
| 171 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83087650 |
| 172 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82513870 |
| 173 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.80951245 |
| 174 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79303607 |
| 175 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78991214 |
| 176 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.77859800 |
| 177 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.76843124 |
| 178 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76757566 |
| 179 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.76548998 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.57805525 |
| 2 | MP0000685_abnormal_immune_system | 3.25382408 |
| 3 | MP0002166_altered_tumor_susceptibility | 3.06478545 |
| 4 | MP0003300_gastrointestinal_ulcer | 3.05716558 |
| 5 | MP0003436_decreased_susceptibility_to | 2.74628927 |
| 6 | MP0001790_abnormal_immune_system | 2.74358860 |
| 7 | MP0005387_immune_system_phenotype | 2.74358860 |
| 8 | MP0005671_abnormal_response_to | 2.61791970 |
| 9 | MP0001800_abnormal_humoral_immune | 2.61192586 |
| 10 | MP0003303_peritoneal_inflammation | 2.55912349 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.52250077 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.49175217 |
| 13 | MP0002006_tumorigenesis | 2.48159150 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.34303255 |
| 15 | MP0001529_abnormal_vocalization | 2.31913074 |
| 16 | * MP0002452_abnormal_antigen_presenting | 2.23901605 |
| 17 | MP0010352_gastrointestinal_tract_polyps | 2.21347701 |
| 18 | MP0009785_altered_susceptibility_to | 2.15819357 |
| 19 | * MP0002723_abnormal_immune_serum | 2.14261248 |
| 20 | MP0002396_abnormal_hematopoietic_system | 2.11225273 |
| 21 | MP0004947_skin_inflammation | 2.07360416 |
| 22 | MP0002254_reproductive_system_inflammat | 2.04744370 |
| 23 | * MP0002420_abnormal_adaptive_immunity | 2.02911283 |
| 24 | * MP0001819_abnormal_immune_cell | 2.02461159 |
| 25 | MP0005025_abnormal_response_to | 1.98573070 |
| 26 | * MP0002398_abnormal_bone_marrow | 1.98459487 |
| 27 | MP0001984_abnormal_olfaction | 1.94550211 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.94239111 |
| 29 | MP0001853_heart_inflammation | 1.90553325 |
| 30 | MP0004510_myositis | 1.87735241 |
| 31 | MP0001873_stomach_inflammation | 1.87294147 |
| 32 | MP0005076_abnormal_cell_differentiation | 1.87085776 |
| 33 | * MP0002419_abnormal_innate_immunity | 1.82929218 |
| 34 | MP0003011_delayed_dark_adaptation | 1.81274912 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.80592374 |
| 36 | * MP0000716_abnormal_immune_system | 1.79442162 |
| 37 | MP0004484_altered_response_of | 1.77909320 |
| 38 | MP0002102_abnormal_ear_morphology | 1.76846900 |
| 39 | MP0002405_respiratory_system_inflammati | 1.72742650 |
| 40 | MP0002009_preneoplasia | 1.69566655 |
| 41 | MP0004808_abnormal_hematopoietic_stem | 1.68687752 |
| 42 | MP0003195_calcinosis | 1.66343033 |
| 43 | MP0006082_CNS_inflammation | 1.65730383 |
| 44 | MP0000427_abnormal_hair_cycle | 1.65578101 |
| 45 | MP0002877_abnormal_melanocyte_morpholog | 1.63665469 |
| 46 | MP0005310_abnormal_salivary_gland | 1.62212265 |
| 47 | * MP0002722_abnormal_immune_system | 1.60302547 |
| 48 | * MP0000703_abnormal_thymus_morphology | 1.58948679 |
| 49 | * MP0000689_abnormal_spleen_morphology | 1.56823304 |
| 50 | * MP0002429_abnormal_blood_cell | 1.49099674 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.48904676 |
| 52 | MP0008789_abnormal_olfactory_epithelium | 1.46857861 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.44464390 |
| 54 | MP0006276_abnormal_autonomic_nervous | 1.43676370 |
| 55 | MP0003724_increased_susceptibility_to | 1.42296253 |
| 56 | MP0003880_abnormal_central_pattern | 1.42263203 |
| 57 | MP0001986_abnormal_taste_sensitivity | 1.42034869 |
| 58 | MP0009333_abnormal_splenocyte_physiolog | 1.41319213 |
| 59 | MP0003453_abnormal_keratinocyte_physiol | 1.34550400 |
| 60 | MP0009278_abnormal_bone_marrow | 1.33798091 |
| 61 | MP0003866_abnormal_defecation | 1.33079754 |
| 62 | MP0008875_abnormal_xenobiotic_pharmacok | 1.32656051 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 1.31631519 |
| 64 | MP0005397_hematopoietic_system_phenotyp | 1.28576297 |
| 65 | MP0001545_abnormal_hematopoietic_system | 1.28576297 |
| 66 | MP0008057_abnormal_DNA_replication | 1.27825492 |
| 67 | MP0008877_abnormal_DNA_methylation | 1.25832530 |
| 68 | MP0001533_abnormal_skeleton_physiology | 1.25506894 |
| 69 | MP0010307_abnormal_tumor_latency | 1.24619428 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 1.22970211 |
| 71 | MP0002933_joint_inflammation | 1.21131938 |
| 72 | MP0005394_taste/olfaction_phenotype | 1.19673791 |
| 73 | MP0005499_abnormal_olfactory_system | 1.19673791 |
| 74 | MP0005253_abnormal_eye_physiology | 1.18871727 |
| 75 | MP0004782_abnormal_surfactant_physiolog | 1.18046604 |
| 76 | MP0003448_altered_tumor_morphology | 1.15514895 |
| 77 | MP0010234_abnormal_vibrissa_follicle | 1.14099754 |
| 78 | MP0004142_abnormal_muscle_tone | 1.12754256 |
| 79 | MP0001348_abnormal_lacrimal_gland | 1.10893538 |
| 80 | MP0000569_abnormal_digit_pigmentation | 1.09868712 |
| 81 | MP0003566_abnormal_cell_adhesion | 1.06396471 |
| 82 | MP0008469_abnormal_protein_level | 1.05256584 |
| 83 | MP0008775_abnormal_heart_ventricle | 1.05176049 |
| 84 | MP0000490_abnormal_crypts_of | 1.04308854 |
| 85 | MP0000858_altered_metastatic_potential | 1.00828148 |
| 86 | MP0009840_abnormal_foam_cell | 1.00742811 |
| 87 | MP0003221_abnormal_cardiomyocyte_apopto | 0.99419513 |
| 88 | MP0002332_abnormal_exercise_endurance | 0.97523059 |
| 89 | MP0006054_spinal_hemorrhage | 0.95263061 |
| 90 | MP0000383_abnormal_hair_follicle | 0.92189715 |
| 91 | MP0001764_abnormal_homeostasis | 0.91926016 |
| 92 | MP0004185_abnormal_adipocyte_glucose | 0.91610414 |
| 93 | MP0003091_abnormal_cell_migration | 0.91104944 |
| 94 | MP0009764_decreased_sensitivity_to | 0.90828124 |
| 95 | MP0000609_abnormal_liver_physiology | 0.90813613 |
| 96 | MP0010678_abnormal_skin_adnexa | 0.88170480 |
| 97 | MP0008873_increased_physiological_sensi | 0.87999125 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.87538650 |
| 99 | MP0002019_abnormal_tumor_incidence | 0.85605311 |
| 100 | MP0008260_abnormal_autophagy | 0.84876487 |
| 101 | MP0005390_skeleton_phenotype | 0.84610401 |
| 102 | MP0008058_abnormal_DNA_repair | 0.83845033 |
| 103 | MP0001501_abnormal_sleep_pattern | 0.83398518 |
| 104 | MP0003191_abnormal_cellular_cholesterol | 0.83064054 |
| 105 | MP0000733_abnormal_muscle_development | 0.82543404 |
| 106 | MP0001881_abnormal_mammary_gland | 0.80553213 |
| 107 | MP0004215_abnormal_myocardial_fiber | 0.79771213 |
| 108 | MP0005248_abnormal_Harderian_gland | 0.79749125 |
| 109 | MP0001216_abnormal_epidermal_layer | 0.79485156 |
| 110 | MP0004885_abnormal_endolymph | 0.79406103 |
| 111 | MP0003172_abnormal_lysosome_physiology | 0.79297206 |
| 112 | MP0001851_eye_inflammation | 0.78847621 |
| 113 | * MP0002998_abnormal_bone_remodeling | 0.78144366 |
| 114 | MP0004924_abnormal_behavior | 0.78119242 |
| 115 | MP0005386_behavior/neurological_phenoty | 0.78119242 |
| 116 | MP0003183_abnormal_peptide_metabolism | 0.77705341 |
| 117 | MP0001502_abnormal_circadian_rhythm | 0.77549645 |
| 118 | MP0005058_abnormal_lysosome_morphology | 0.76959445 |
| 119 | * MP0000647_abnormal_sebaceous_gland | 0.76490457 |
| 120 | MP0006035_abnormal_mitochondrial_morpho | 0.75034845 |
| 121 | * MP0002095_abnormal_skin_pigmentation | 0.74666494 |
| 122 | MP0005646_abnormal_pituitary_gland | 0.73952089 |
| 123 | MP0002928_abnormal_bile_duct | 0.72806656 |
| 124 | MP0009763_increased_sensitivity_to | 0.71079195 |
| 125 | MP0000371_diluted_coat_color | 0.69791310 |
| 126 | MP0005023_abnormal_wound_healing | 0.69734431 |
| 127 | MP0001849_ear_inflammation | 0.69133717 |
| 128 | MP0002098_abnormal_vibrissa_morphology | 0.66400601 |
| 129 | MP0001915_intracranial_hemorrhage | 0.65674403 |
| 130 | MP0000627_abnormal_mammary_gland | 0.65473677 |
| 131 | MP0002736_abnormal_nociception_after | 0.65186088 |
| 132 | MP0000015_abnormal_ear_pigmentation | 0.65052988 |
| 133 | * MP0000598_abnormal_liver_morphology | 0.64907251 |
| 134 | MP0003252_abnormal_bile_duct | 0.64526360 |
| 135 | MP0001191_abnormal_skin_condition | 0.64056413 |
| 136 | MP0008961_abnormal_basal_metabolism | 0.63135162 |
| 137 | MP0001879_abnormal_lymphatic_vessel | 0.62726344 |
| 138 | MP0003077_abnormal_cell_cycle | 0.62287034 |
| 139 | MP0003828_pulmonary_edema | 0.61342090 |
| 140 | MP0001346_abnormal_lacrimal_gland | 0.61280725 |
| 141 | MP0002136_abnormal_kidney_physiology | 0.60966403 |
| 142 | MP0001243_abnormal_dermal_layer | 0.60800802 |
| 143 | MP0002277_abnormal_respiratory_mucosa | 0.60402047 |
| 144 | MP0004147_increased_porphyrin_level | 0.60202234 |
| 145 | MP0010094_abnormal_chromosome_stability | 0.59154433 |
| 146 | MP0005084_abnormal_gallbladder_morpholo | 0.59056721 |
| 147 | MP0001919_abnormal_reproductive_system | 0.58910514 |
| 148 | MP0002751_abnormal_autonomic_nervous | 0.56209138 |
| 149 | MP0008007_abnormal_cellular_replicative | 0.53460645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent viral infections (HP:0004429) | 4.67022973 |
| 2 | Recurrent fungal infections (HP:0002841) | 4.42492377 |
| 3 | T lymphocytopenia (HP:0005403) | 4.04710933 |
| 4 | Abnormality of T cell number (HP:0011839) | 4.02978285 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.01844315 |
| 6 | Abnormality of the fingertips (HP:0001211) | 3.55648704 |
| 7 | Chronic otitis media (HP:0000389) | 3.51406602 |
| 8 | Panhypogammaglobulinemia (HP:0003139) | 3.47735447 |
| 9 | Methylmalonic acidemia (HP:0002912) | 3.37788065 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.33469833 |
| 11 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.27570558 |
| 12 | Recurrent cutaneous fungal infections (HP:0011370) | 3.27570558 |
| 13 | Medial flaring of the eyebrow (HP:0010747) | 3.14394105 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 3.11942365 |
| 15 | Autoimmune thrombocytopenia (HP:0001973) | 3.11203811 |
| 16 | Myositis (HP:0100614) | 3.08278141 |
| 17 | Abnormality of T cells (HP:0002843) | 3.05797085 |
| 18 | Cellulitis (HP:0100658) | 3.05147414 |
| 19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.95117955 |
| 20 | Increased IgE level (HP:0003212) | 2.95027872 |
| 21 | Thyroiditis (HP:0100646) | 2.94651474 |
| 22 | Agammaglobulinemia (HP:0004432) | 2.94594412 |
| 23 | Abnormality of B cell number (HP:0010975) | 2.94578106 |
| 24 | B lymphocytopenia (HP:0010976) | 2.94578106 |
| 25 | Eosinophilia (HP:0001880) | 2.91006945 |
| 26 | Lipid accumulation in hepatocytes (HP:0006561) | 2.90555922 |
| 27 | Recurrent skin infections (HP:0001581) | 2.87495730 |
| 28 | Recurrent abscess formation (HP:0002722) | 2.86578872 |
| 29 | Nephrogenic diabetes insipidus (HP:0009806) | 2.86507759 |
| 30 | Progressive inability to walk (HP:0002505) | 2.81390497 |
| 31 | Congenital primary aphakia (HP:0007707) | 2.80911087 |
| 32 | Severe combined immunodeficiency (HP:0004430) | 2.75779846 |
| 33 | Gait imbalance (HP:0002141) | 2.74995124 |
| 34 | Hematochezia (HP:0002573) | 2.74750626 |
| 35 | Meningitis (HP:0001287) | 2.74686461 |
| 36 | Chronic hepatic failure (HP:0100626) | 2.73938437 |
| 37 | Arterial thrombosis (HP:0004420) | 2.72575024 |
| 38 | Retrobulbar optic neuritis (HP:0100654) | 2.71859271 |
| 39 | Optic neuritis (HP:0100653) | 2.71859271 |
| 40 | Loss of speech (HP:0002371) | 2.71390970 |
| 41 | Vasculitis (HP:0002633) | 2.70877876 |
| 42 | Thrombocytosis (HP:0001894) | 2.69978334 |
| 43 | Verrucae (HP:0200043) | 2.69527811 |
| 44 | Papilloma (HP:0012740) | 2.69527811 |
| 45 | Mediastinal lymphadenopathy (HP:0100721) | 2.65195351 |
| 46 | Chronic diarrhea (HP:0002028) | 2.64746069 |
| 47 | Orchitis (HP:0100796) | 2.64577425 |
| 48 | Spontaneous hematomas (HP:0007420) | 2.63964284 |
| 49 | Inflammation of the large intestine (HP:0002037) | 2.63121769 |
| 50 | Pancreatic cysts (HP:0001737) | 2.62860411 |
| 51 | Lissencephaly (HP:0001339) | 2.61606613 |
| 52 | Recurrent bronchitis (HP:0002837) | 2.59599936 |
| 53 | Gastrointestinal inflammation (HP:0004386) | 2.58441125 |
| 54 | Combined immunodeficiency (HP:0005387) | 2.58397569 |
| 55 | Gingival bleeding (HP:0000225) | 2.56493538 |
| 56 | Rimmed vacuoles (HP:0003805) | 2.54380523 |
| 57 | Leukocytosis (HP:0001974) | 2.52277439 |
| 58 | Myocardial infarction (HP:0001658) | 2.50688893 |
| 59 | Increased hepatocellular lipid droplets (HP:0006565) | 2.49676903 |
| 60 | Postaxial foot polydactyly (HP:0001830) | 2.46921118 |
| 61 | Granulocytopenia (HP:0001913) | 2.45635167 |
| 62 | Colitis (HP:0002583) | 2.44151593 |
| 63 | Osteomyelitis (HP:0002754) | 2.42621478 |
| 64 | Pulmonary infiltrates (HP:0002113) | 2.41464849 |
| 65 | Methylmalonic aciduria (HP:0012120) | 2.40706484 |
| 66 | Abnormality of T cell physiology (HP:0011840) | 2.40486428 |
| 67 | Amyotrophic lateral sclerosis (HP:0007354) | 2.39708451 |
| 68 | Fatigue (HP:0012378) | 2.39460770 |
| 69 | IgM deficiency (HP:0002850) | 2.37102708 |
| 70 | Stomatitis (HP:0010280) | 2.35756821 |
| 71 | Abnormality of eosinophils (HP:0001879) | 2.35117369 |
| 72 | Median cleft lip (HP:0000161) | 2.33864703 |
| 73 | Interstitial pulmonary disease (HP:0006530) | 2.31824946 |
| 74 | IgA deficiency (HP:0002720) | 2.31812813 |
| 75 | Osteolytic defects of the hand bones (HP:0009699) | 2.30649507 |
| 76 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.30649507 |
| 77 | Nasal polyposis (HP:0100582) | 2.29871200 |
| 78 | Hypoplasia of the thymus (HP:0000778) | 2.29320170 |
| 79 | Retinal dysplasia (HP:0007973) | 2.29086259 |
| 80 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.25195172 |
| 81 | Short 4th metacarpal (HP:0010044) | 2.25195172 |
| 82 | Gastrointestinal infarctions (HP:0005244) | 2.20810328 |
| 83 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.20711948 |
| 84 | Type II lissencephaly (HP:0007260) | 2.20476667 |
| 85 | Lymphopenia (HP:0001888) | 2.20440164 |
| 86 | Abnormality of the renal cortex (HP:0011035) | 2.18775186 |
| 87 | Absent speech (HP:0001344) | 2.18196441 |
| 88 | Abnormality of macrophages (HP:0004311) | 2.16167819 |
| 89 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.15031408 |
| 90 | Asymmetric septal hypertrophy (HP:0001670) | 2.14547208 |
| 91 | Attenuation of retinal blood vessels (HP:0007843) | 2.13985880 |
| 92 | Widely spaced teeth (HP:0000687) | 2.13706078 |
| 93 | IgG deficiency (HP:0004315) | 2.13569186 |
| 94 | Hemoptysis (HP:0002105) | 2.12983169 |
| 95 | Acute myeloid leukemia (HP:0004808) | 2.10541911 |
| 96 | Long clavicles (HP:0000890) | 2.09720698 |
| 97 | True hermaphroditism (HP:0010459) | 2.09520026 |
| 98 | Increased density of long bones (HP:0006392) | 2.09504415 |
| 99 | Cutis marmorata (HP:0000965) | 2.09167947 |
| 100 | Hyperventilation (HP:0002883) | 2.08645645 |
| 101 | Esophageal varix (HP:0002040) | 2.08267327 |
| 102 | Chest pain (HP:0100749) | 2.06104934 |
| 103 | Persistence of primary teeth (HP:0006335) | 2.05907100 |
| 104 | Pancreatic fibrosis (HP:0100732) | 2.04314013 |
| 105 | * Periodontitis (HP:0000704) | 2.03743419 |
| 106 | Facial diplegia (HP:0001349) | 2.03413729 |
| 107 | Keratoconjunctivitis (HP:0001096) | 2.00862450 |
| 108 | Abolished electroretinogram (ERG) (HP:0000550) | 2.00768752 |
| 109 | Epistaxis (HP:0000421) | 1.99753403 |
| 110 | 3-Methylglutaconic aciduria (HP:0003535) | 1.99310826 |
| 111 | Abnormality of the nasal mucosa (HP:0000433) | 1.99041310 |
| 112 | Drooling (HP:0002307) | 1.97181511 |
| 113 | Skin ulcer (HP:0200042) | 1.97177379 |
| 114 | Gastrointestinal stroma tumor (HP:0100723) | 1.96538852 |
| 115 | Stomach cancer (HP:0012126) | 1.96346207 |
| 116 | Cone-rod dystrophy (HP:0000548) | 1.94816369 |
| 117 | Hypochromic microcytic anemia (HP:0004840) | 1.94405733 |
| 118 | Neutropenia (HP:0001875) | 1.93987630 |
| 119 | Type 2 muscle fiber atrophy (HP:0003554) | 1.93640247 |
| 120 | Vaginal atresia (HP:0000148) | 1.92764536 |
| 121 | Abnormality of the renal medulla (HP:0100957) | 1.92495449 |
| 122 | Keratoconjunctivitis sicca (HP:0001097) | 1.91916924 |
| 123 | Genital tract atresia (HP:0001827) | 1.91278452 |
| 124 | Hypothermia (HP:0002045) | 1.91096139 |
| 125 | Excessive salivation (HP:0003781) | 1.90814862 |
| 126 | Volvulus (HP:0002580) | 1.90630793 |
| 127 | Hypergammaglobulinemia (HP:0010702) | 1.89565579 |
| 128 | Papillary thyroid carcinoma (HP:0002895) | 1.89295601 |
| 129 | Joint swelling (HP:0001386) | 1.88487576 |
| 130 | Abnormal platelet volume (HP:0011876) | 1.87177361 |
| 131 | Pulmonary embolism (HP:0002204) | 1.86695385 |
| 132 | Renal Fanconi syndrome (HP:0001994) | 1.86189980 |
| 133 | Encephalitis (HP:0002383) | 1.86157904 |
| 134 | Hyperglycinemia (HP:0002154) | 1.86007512 |
| 135 | Abnormality of midbrain morphology (HP:0002418) | 1.86005880 |
| 136 | Molar tooth sign on MRI (HP:0002419) | 1.86005880 |
| 137 | Amaurosis fugax (HP:0100576) | 1.85077476 |
| 138 | Specific learning disability (HP:0001328) | 1.84714457 |
| 139 | Pustule (HP:0200039) | 1.83692922 |
| 140 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.82885716 |
| 141 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.82885716 |
| 142 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.82885716 |
| 143 | Abnormality of skull ossification (HP:0002703) | 1.82878046 |
| 144 | Generalized aminoaciduria (HP:0002909) | 1.82380097 |
| 145 | Disproportionate short-trunk short stature (HP:0003521) | 1.81869636 |
| 146 | Postaxial hand polydactyly (HP:0001162) | 1.81730929 |
| 147 | Macroorchidism (HP:0000053) | 1.81237297 |
| 148 | Emphysema (HP:0002097) | 1.81166713 |
| 149 | Abnormal biliary tract physiology (HP:0012439) | 1.81057956 |
| 150 | Bile duct proliferation (HP:0001408) | 1.81057956 |
| 151 | Keratitis (HP:0000491) | 1.80501403 |
| 152 | Portal hypertension (HP:0001409) | 1.79670792 |
| 153 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.79490362 |
| 154 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.79479781 |
| 155 | Mucopolysacchariduria (HP:0008155) | 1.79479781 |
| 156 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.79145364 |
| 157 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.79145364 |
| 158 | Exertional dyspnea (HP:0002875) | 1.78719256 |
| 159 | Cutaneous melanoma (HP:0012056) | 1.78641355 |
| 160 | Hypokalemic alkalosis (HP:0001949) | 1.78302760 |
| 161 | Inability to walk (HP:0002540) | 1.77353609 |
| 162 | Toxemia of pregnancy (HP:0100603) | 1.77183539 |
| 163 | Autoimmune hemolytic anemia (HP:0001890) | 1.77160096 |
| 164 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.76805015 |
| 165 | Increased cerebral lipofuscin (HP:0011813) | 1.76098925 |
| 166 | Lymphoma (HP:0002665) | 1.76081362 |
| 167 | Sepsis (HP:0100806) | 1.73769961 |
| 168 | Chronic obstructive pulmonary disease (HP:0006510) | 1.73234371 |
| 169 | Obstructive lung disease (HP:0006536) | 1.73234371 |
| 170 | Gingivitis (HP:0000230) | 1.71025140 |
| 171 | Thrombophlebitis (HP:0004418) | 1.70687147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.64874530 |
| 2 | TESK2 | 3.16417906 |
| 3 | MAP3K14 | 3.09894464 |
| 4 | JAK3 | 2.93668373 |
| 5 | BCKDK | 2.75143978 |
| 6 | TXK | 2.65837311 |
| 7 | MAP3K10 | 2.63277222 |
| 8 | TYK2 | 2.61388027 |
| 9 | NUAK1 | 2.55538427 |
| 10 | FGFR4 | 2.50528868 |
| 11 | BCR | 2.39823845 |
| 12 | ACVR1B | 2.31856085 |
| 13 | MAP3K4 | 2.27119992 |
| 14 | CDK12 | 2.24544302 |
| 15 | EEF2K | 2.15171578 |
| 16 | STK10 | 2.12272823 |
| 17 | TBK1 | 2.09897813 |
| 18 | FGFR3 | 2.06775322 |
| 19 | NEK1 | 2.05027963 |
| 20 | TRIB3 | 2.04195776 |
| 21 | JAK1 | 1.89253823 |
| 22 | IKBKB | 1.84817166 |
| 23 | CHUK | 1.84408105 |
| 24 | ERN1 | 1.83744353 |
| 25 | ZAP70 | 1.82895927 |
| 26 | EPHB1 | 1.79700954 |
| 27 | IKBKE | 1.78876571 |
| 28 | ITK | 1.76827916 |
| 29 | PKN2 | 1.74449737 |
| 30 | WNK3 | 1.70816278 |
| 31 | PTK6 | 1.67359147 |
| 32 | GRK7 | 1.60049935 |
| 33 | BTK | 1.54076747 |
| 34 | ERBB3 | 1.52642898 |
| 35 | TLK1 | 1.44083169 |
| 36 | CDC42BPA | 1.41390865 |
| 37 | LRRK2 | 1.40253664 |
| 38 | RPS6KA4 | 1.39282286 |
| 39 | FLT3 | 1.39029590 |
| 40 | EPHA3 | 1.38275570 |
| 41 | IRAK4 | 1.36445492 |
| 42 | MAP2K7 | 1.36049101 |
| 43 | SIK3 | 1.33382052 |
| 44 | MAP3K13 | 1.32818734 |
| 45 | SIK1 | 1.31447780 |
| 46 | KIT | 1.29581478 |
| 47 | NLK | 1.25483977 |
| 48 | GRK6 | 1.25370557 |
| 49 | ADRBK2 | 1.24173140 |
| 50 | MAP4K2 | 1.23326738 |
| 51 | NEK9 | 1.23009562 |
| 52 | SGK2 | 1.22986924 |
| 53 | SYK | 1.22834261 |
| 54 | CDK6 | 1.21623853 |
| 55 | TAOK3 | 1.21613547 |
| 56 | TRIM28 | 1.20725362 |
| 57 | CSF1R | 1.18604549 |
| 58 | CDK8 | 1.18287734 |
| 59 | JAK2 | 1.15935822 |
| 60 | HCK | 1.15830730 |
| 61 | TIE1 | 1.14047594 |
| 62 | MARK1 | 1.13940612 |
| 63 | FGFR2 | 1.12878098 |
| 64 | TGFBR2 | 1.12147896 |
| 65 | EIF2AK3 | 1.11536519 |
| 66 | LCK | 1.10493108 |
| 67 | CSK | 1.10272807 |
| 68 | PIM1 | 1.08481489 |
| 69 | CAMK1D | 1.06255338 |
| 70 | TNK2 | 1.03623311 |
| 71 | BMPR1B | 1.02917589 |
| 72 | TEC | 1.02301361 |
| 73 | AKT3 | 1.00073439 |
| 74 | OBSCN | 0.96293651 |
| 75 | MAPK13 | 0.94433744 |
| 76 | CDK4 | 0.91411735 |
| 77 | STK4 | 0.90720726 |
| 78 | BRD4 | 0.87744598 |
| 79 | FER | 0.87171952 |
| 80 | HIPK2 | 0.84622243 |
| 81 | CDK3 | 0.84420421 |
| 82 | SRPK1 | 0.83622672 |
| 83 | PAK3 | 0.82640188 |
| 84 | BLK | 0.82636941 |
| 85 | ZAK | 0.81762553 |
| 86 | MAP2K3 | 0.81166782 |
| 87 | STK3 | 0.80875227 |
| 88 | MAP3K7 | 0.78282674 |
| 89 | CSNK1A1L | 0.78139503 |
| 90 | CDK9 | 0.77451416 |
| 91 | PASK | 0.75576963 |
| 92 | IRAK1 | 0.74237836 |
| 93 | IRAK3 | 0.72417638 |
| 94 | PIM2 | 0.72096546 |
| 95 | PDGFRB | 0.70072538 |
| 96 | LYN | 0.69387153 |
| 97 | DYRK3 | 0.68753347 |
| 98 | TGFBR1 | 0.67746565 |
| 99 | MAP3K8 | 0.66472982 |
| 100 | PRKCQ | 0.65714358 |
| 101 | TTN | 0.65396670 |
| 102 | MATK | 0.65282435 |
| 103 | MAPK11 | 0.64937350 |
| 104 | CAMK1G | 0.63891764 |
| 105 | MTOR | 0.63784886 |
| 106 | ADRBK1 | 0.61913417 |
| 107 | TNIK | 0.61892489 |
| 108 | RET | 0.61883317 |
| 109 | DYRK1B | 0.61762902 |
| 110 | NEK2 | 0.61711703 |
| 111 | RAF1 | 0.61180828 |
| 112 | SGK223 | 0.60800355 |
| 113 | SGK494 | 0.60800355 |
| 114 | ALK | 0.59741288 |
| 115 | CLK1 | 0.57826116 |
| 116 | MELK | 0.57145216 |
| 117 | MKNK1 | 0.56278111 |
| 118 | PRKCH | 0.56224154 |
| 119 | DMPK | 0.55180601 |
| 120 | BMX | 0.55135345 |
| 121 | INSRR | 0.54456407 |
| 122 | CSNK1G1 | 0.54306572 |
| 123 | MAP3K5 | 0.54110766 |
| 124 | FRK | 0.52560588 |
| 125 | MAPKAPK2 | 0.52340024 |
| 126 | PLK2 | 0.51757807 |
| 127 | CSNK1G3 | 0.50217819 |
| 128 | PRKAA2 | 0.49819838 |
| 129 | MKNK2 | 0.48935451 |
| 130 | MARK3 | 0.48723342 |
| 131 | EGFR | 0.48657907 |
| 132 | TRPM7 | 0.47856049 |
| 133 | SGK3 | 0.47065641 |
| 134 | RPS6KA5 | 0.46932057 |
| 135 | STK24 | 0.45945848 |
| 136 | RIPK1 | 0.44676320 |
| 137 | FGFR1 | 0.44370337 |
| 138 | RPS6KB2 | 0.43109809 |
| 139 | CDK19 | 0.42707596 |
| 140 | MAP3K3 | 0.42059250 |
| 141 | PAK6 | 0.41731510 |
| 142 | LATS1 | 0.41204825 |
| 143 | KDR | 0.39296143 |
| 144 | ABL1 | 0.39197079 |
| 145 | FGR | 0.38820710 |
| 146 | FES | 0.38568186 |
| 147 | ATR | 0.37201621 |
| 148 | MAPK7 | 0.36801301 |
| 149 | MAP2K2 | 0.36157219 |
| 150 | MST4 | 0.34655132 |
| 151 | SCYL2 | 0.34120752 |
| 152 | RPS6KA1 | 0.31330589 |
| 153 | IGF1R | 0.30120519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.94175524 |
| 2 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.85903185 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.46708388 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.34462214 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.29615113 |
| 6 | * Leishmaniasis_Homo sapiens_hsa05140 | 2.29083983 |
| 7 | * Measles_Homo sapiens_hsa05162 | 2.27036035 |
| 8 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.20048150 |
| 9 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.18393531 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.16655386 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.12796957 |
| 12 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.08092070 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.98903137 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.97862143 |
| 15 | Circadian rhythm_Homo sapiens_hsa04710 | 1.96895027 |
| 16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.94938449 |
| 17 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.92764585 |
| 18 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.81143124 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.78435019 |
| 20 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.76111921 |
| 21 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.70268827 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.66285302 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.62796429 |
| 24 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.62072525 |
| 25 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.55278806 |
| 26 | Basal transcription factors_Homo sapiens_hsa03022 | 1.54384335 |
| 27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.53534468 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.52943675 |
| 29 | Legionellosis_Homo sapiens_hsa05134 | 1.51343221 |
| 30 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46875842 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.46438835 |
| 32 | Protein export_Homo sapiens_hsa03060 | 1.44485785 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.42127275 |
| 34 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.42073879 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.40246397 |
| 36 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.39601753 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.39385342 |
| 38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.39200334 |
| 39 | RNA degradation_Homo sapiens_hsa03018 | 1.28849741 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.28111611 |
| 41 | * Small cell lung cancer_Homo sapiens_hsa05222 | 1.27271301 |
| 42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.27166071 |
| 43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.26816683 |
| 44 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.26694542 |
| 45 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.25541811 |
| 46 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.23368191 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23356320 |
| 48 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.23282100 |
| 49 | Asthma_Homo sapiens_hsa05310 | 1.18103113 |
| 50 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.17378744 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.17366769 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 1.16627328 |
| 53 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16297326 |
| 54 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.16097124 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.16020092 |
| 56 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.14184705 |
| 57 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.13104824 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11953746 |
| 59 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.11517684 |
| 60 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10241165 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 1.10106294 |
| 62 | * Tuberculosis_Homo sapiens_hsa05152 | 1.07790140 |
| 63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07759348 |
| 64 | * Pertussis_Homo sapiens_hsa05133 | 1.07679887 |
| 65 | Malaria_Homo sapiens_hsa05144 | 1.06408553 |
| 66 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.05010766 |
| 67 | HTLV-I infection_Homo sapiens_hsa05166 | 1.03840736 |
| 68 | Phototransduction_Homo sapiens_hsa04744 | 1.03687755 |
| 69 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.02397697 |
| 70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.00795854 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.98981950 |
| 72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.97040491 |
| 73 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.96260216 |
| 74 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.95407270 |
| 75 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.92465197 |
| 76 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.92069519 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91636701 |
| 78 | * Hepatitis C_Homo sapiens_hsa05160 | 0.88498391 |
| 79 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.86093579 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85995775 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.84090704 |
| 82 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82140960 |
| 83 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.81774752 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.81408085 |
| 85 | Prostate cancer_Homo sapiens_hsa05215 | 0.80302826 |
| 86 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.79229186 |
| 87 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74736929 |
| 88 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.73303364 |
| 89 | Peroxisome_Homo sapiens_hsa04146 | 0.73245105 |
| 90 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.71749742 |
| 91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70018229 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.68153362 |
| 93 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.67365165 |
| 94 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.67354033 |
| 95 | * Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.66993348 |
| 96 | Homologous recombination_Homo sapiens_hsa03440 | 0.66835692 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65605379 |
| 98 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.63106613 |
| 99 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.62319119 |
| 100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62118549 |
| 101 | Proteasome_Homo sapiens_hsa03050 | 0.60457200 |
| 102 | Salmonella infection_Homo sapiens_hsa05132 | 0.60116310 |
| 103 | Colorectal cancer_Homo sapiens_hsa05210 | 0.56745354 |
| 104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55249622 |
| 105 | Adherens junction_Homo sapiens_hsa04520 | 0.54307982 |
| 106 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.52904687 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52250480 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51976877 |
| 109 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51904692 |
| 110 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.50647742 |
| 111 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.50526292 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49462503 |
| 113 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48667454 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | 0.48380726 |
| 115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47944555 |
| 116 | Amoebiasis_Homo sapiens_hsa05146 | 0.46713401 |
| 117 | Lysosome_Homo sapiens_hsa04142 | 0.46457887 |
| 118 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45433074 |
| 119 | Taste transduction_Homo sapiens_hsa04742 | 0.43688479 |
| 120 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42330207 |
| 121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41894217 |
| 122 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41291949 |
| 123 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40891828 |
| 124 | Phagosome_Homo sapiens_hsa04145 | 0.40543001 |
| 125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38823634 |
| 126 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.38511850 |
| 127 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37497631 |
| 128 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.35186585 |
| 129 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.35067960 |
| 130 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.34587137 |
| 131 | Other glycan degradation_Homo sapiens_hsa00511 | 0.31600693 |
| 132 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.31331159 |
| 133 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30631163 |
| 134 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.30603319 |
| 135 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30258505 |
| 136 | Cell cycle_Homo sapiens_hsa04110 | 0.30210100 |
| 137 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.29809574 |
| 138 | Focal adhesion_Homo sapiens_hsa04510 | 0.28533947 |
| 139 | Olfactory transduction_Homo sapiens_hsa04740 | 0.28476462 |
| 140 | Glioma_Homo sapiens_hsa05214 | 0.27993916 |
| 141 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.24645268 |
| 142 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.24634400 |
| 143 | Mismatch repair_Homo sapiens_hsa03430 | 0.24400434 |
| 144 | RNA polymerase_Homo sapiens_hsa03020 | 0.24236964 |
| 145 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.22172788 |
| 146 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.22006838 |
| 147 | Purine metabolism_Homo sapiens_hsa00230 | 0.21411205 |

